|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Share-based compensation expense related to equity incentive plans | |||||
| Loss on settlement of debt | |||||
| Amortization of debt discount | |||||
| Amortization of debt issuance costs | |||||
| Impairment of intangible assets | |||||
| Other | |||||
| Changes in operating assets and liabilities, excluding impact of acquisitions: | |||||
| (Increase) decrease in accounts receivable | |||||
| Decrease in inventories | |||||
| Increase (decrease) in accounts payable and accrued liabilities | |||||
| Change in other assets and liabilities | |||||
| Change in income tax payable | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Other investing | |||||
| Proceeds from capital-related government incentives | |||||
| Investments in other assets | |||||
| Capital expenditures | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings on Revolving Credit Facility | |||||
| Total proceeds from borrowings on Revolving Credit Facility | |||||
| Repayments of Revolving Credit Facility | |||||
| Total repayments of Revolving Credit Facility | |||||
| Proceeds from borrowings on 2025 Term Loan Facility | |||||
| Repayments of 2025 Term Loan Facility | |||||
| Proceeds from issuance of Commercial Paper | |||||
| Repayments of Commercial Paper | |||||
| Proceeds from issuance of senior notes | |||||
| Repayment of senior notes | |||||
| Proceeds from issuance of convertible debt | |||||
| Payments on settlement of convertible debt | |||||
| Issuance of Series A Preferred Stock | |||||
| Deferred financing costs | |||||
| Purchase of capped call options | |||||
| Proceeds from sale of common stock | |||||
| Tax payments related to shares withheld for vested RSUs | |||||
| Repurchase of common stock | |||||
| Payment of cash dividends on Series A Preferred Stock | |||||
| Payment of cash dividends on common stock | |||||
| Capital lease payments | |||||
| Other Financing | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of period | |||||
| Cash and cash equivalents, at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| ROU assets obtained in exchange of lease liabilities | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| U.S. federal | |||||
| U.S. state and local | |||||
| Foreign income taxes | |||||
| Germany | |||||
| Malta | |||||
| Other foreign jurisdictions | |||||
| Operating lease payments in operating cash flows | |||||
Loading...